Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Esophageal Neoplasms × Standard of Care × Clear all

Phase

Status

Completed 3 Unknown 1 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 16 Prostatic Neoplasms 15 Breast Neoplasms 13 Carcinoma, Non-Small-Cell Lung 10 Lung Neoplasms 8 Colorectal Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 6 Neoplasm Metastasis 6 Hematologic Neoplasms 6 Urinary Bladder Neoplasms 5 Hematopoietic and Lymphatic System Neoplasm 5 Pancreatic Neoplasms 4 Carcinoma, Renal Cell 4 Triple Negative Breast Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Multiple Myeloma 3 Motor Activity 3 Melanoma 3 Leukemia, Myeloid, Acute 3 Sarcoma 2 Radiodermatitis 2 Pathologic Complete Response 2 Ovarian Neoplasms 2 Mouth Neoplasms 2 Malignant Solid Neoplasm 2 Hematopoietic and Lymphoid System Neoplasm 2 Hemangiosarcoma 2 Head and Neck Neoplasms 2 Glioblastoma 2 Fallopian Tube Neoplasms 2

Interventions

Paclitaxel 15 pembrolizumab 14 Radiotherapy 11 Cisplatin 11 Esophagectomy 9 Drug Therapy 9 Carboplatin 9 Radiation 8 Nivolumab 7 Immunotherapy 7 Fluorouracil 7 Blood Specimen Collection 7 Chemoradiotherapy 6 Capecitabine 6 Surgical Procedures, Operative 5 Oxaliplatin 5 Immune Checkpoint Inhibitors 5 nimotuzumab 4 Trastuzumab 4 130-nm albumin-bound paclitaxel 4 trastuzumab deruxtecan 3 tislelizumab 3 patritumab deruxtecan 3 camrelizumab 3 Surveys and Questionnaires 3 Specimen Handling 3 Ramucirumab 3 Magnetic Resonance Spectroscopy 3 Leucovorin 3 Endoscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05865743 2025-03-05

PERSuaDER

Radboud University Medical Center

Phase 3 Recruiting

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡